FOXP3 and neoplasm: These analyses showed that in both tumor microenvironments, IL-10 treatment caused a significant increase of CD4+granzyme+ T cells with a concomitant decrease of CD4+CD25+FoxP3+ Treg, reminiscent of what observed after vaccination with gp10025-33 peptide-pulsed DC (Figure 5).